Cancer blood test maker Freenome going public with $330M SPAC
Article Title: Cancer blood test maker Freenome going public with $330M SPAC Publication Date: December 5, 2025 As noted on December 5, 2025, Freenome Holdings Inc., best known for its innovative work in cancer detection, has announced its decision to…
